Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 11, 2026, 9:44 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 2161–2184 of 8,272 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Age Clear all

Conditions: Burns
Interventions: Caldolor, Placebo; Drug
Lead sponsor: Cumberland Pharmaceuticals; Industry
Eligibility: Not listed
Enrollment: 61 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2009
U.S. locations: 2
States / cities: Orlando, Florida • Winston-Salem, North Carolina

Conditions: Dental Plaque
Interventions: Livionex® Dental Gel, PreviDent 5000 plus/Tom's of Maine Children's toothpaste, Kolibree Toothbrush; Drug · Device
Lead sponsor: University of California, San Francisco; Other
Eligibility: Not listed
Enrollment: 44 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2020
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Aging
Interventions: Observational; Other
Lead sponsor: Buck Institute for Research on Aging; Other
Eligibility: 65 Years to 80 Years
Enrollment: 80 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Novato, California

Conditions: COVID-19
Interventions: CareSuperb COVID-19 Antigen Home Test Kit; Device
Lead sponsor: AccessBio, Inc.; Other
Eligibility: 2 Years and older
Enrollment: 786 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023
U.S. locations: 1
States / cities: Miami, Florida

Conditions: Acute Musculoskeletal Pain
Interventions: Standard of Care Analgesia, Standard of Care Analgesia + Virtual Reality; Other
Lead sponsor: Antonios Likourezos; Other
Eligibility: 65 Years to 120 Years
Enrollment: 180 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Brooklyn, New York

Conditions: Necrotizing Enterocolitis, Intra-abdominal Infection
Interventions: meropenem; Drug
Lead sponsor: The Emmes Company, LLC; Industry
Eligibility: Up to 90 Days
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2009
U.S. locations: 26
States / cities: Birmingham, Alabama • Oakland, California • Orange, California + 21 more

Conditions: Kidney Cancer, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms, Neuroblastoma, Neutropenia, Sarcoma
Interventions: voriconazole; Drug
Lead sponsor: National Cancer Institute (NCI); NIH
Eligibility: 2 Years to 11 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2004
U.S. locations: 7
States / cities: Orange, California • San Diego, California • Bethesda, Maryland + 4 more

Conditions: Patent Ductus Arteriosus After Premature Birth
Interventions: Ibuprofen; Drug
Lead sponsor: IWK Health Centre; Other
Eligibility: Up to 72 Hours
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 3
States / cities: Orange, California • San Diego, California • Oklahoma City, Oklahoma

Conditions: SARS-CoV-2 Infection, COVID-19
Interventions: BNT162b1, BNT162b2, Placebo, BNT162b2SA; Biological · Other
Lead sponsor: BioNTech SE; Industry
Eligibility: 12 Years and older
Enrollment: 46,969 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2023
U.S. locations: 154
States / cities: Athens, Alabama • Birmingham, Alabama • Huntsville, Alabama + 106 more

Conditions: Oxidative Stress, Alzheimer's Disease, Aging
Interventions: Not listed
Lead sponsor: University of Minnesota; Other
Eligibility: 65 Years to 89 Years
Enrollment: 52 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2018
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Smokers, Elderly, Asthma, COPD, Recurrent Infections
Interventions: PPV-23; Biological
Lead sponsor: National Jewish Health; Other
Eligibility: 19 Years to 80 Years
Enrollment: 140 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: Denver, Colorado

Conditions: Esophageal Cancer, Gastric Cancer
Interventions: epirubicin, cisplatin, capecitabine, bevacizumab, docetaxel and irinotecan; Drug
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 22 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2015
U.S. locations: 5
States / cities: Basking Ridge, New Jersey • Commack, New York • New York, New York + 2 more

Conditions: Breast Cancer
Interventions: Comprehensive Health Enhancement Support System (CHESS.); Behavioral
Lead sponsor: University of Wisconsin, Madison; Other
Eligibility: 18 Years and older · Female only
Enrollment: 130 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2013
U.S. locations: 1
States / cities: Madison, Wisconsin

Conditions: Premature Birth
Interventions: Not listed
Lead sponsor: University of Minnesota; Other
Eligibility: 25 Weeks to 34 Weeks
Enrollment: 37 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Anthrax
Interventions: BioThrax, AV7909, Sodium chloride injection USP, 0.9% (placebo); Biological · Drug
Lead sponsor: Biomedical Advanced Research and Development Authority; Federal
Eligibility: 18 Years and older
Enrollment: 305 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2019
U.S. locations: 4
States / cities: Lenexa, Kansas • Mt. Pleasant, South Carolina • Nashville, Tennessee + 1 more

Conditions: Neurodevelopmental Disorders, Intellectual Disability, Development Delay, ADHD, Autism Spectrum Disorder, Epilepsy
Interventions: Sulfonylurea; Drug
Lead sponsor: Royal Devon and Exeter NHS Foundation Trust; Other
Eligibility: 2 Years to 50 Years
Enrollment: 21 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2025
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Anemia, Leukemia, Neutropenia, Thrombocytopenia
Interventions: filgrastim, leridistim, cytarabine, daunorubicin hydrochloride; Biological · Drug
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: 55 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1999 – 2000
U.S. locations: 1
States / cities: New York, New York

Conditions: Asthma
Interventions: Albuterol Sulfate; Drug
Lead sponsor: Teva Branded Pharmaceutical Products R&D, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 397 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2018
U.S. locations: 44
States / cities: Litchfield Park, Arizona • Bakersfield, California • Los Angeles, California + 37 more

Conditions: Prostate Cancer, Colon Cancer
Interventions: Not listed
Lead sponsor: Scripps Translational Science Institute; Other
Eligibility: 18 Years and older
Enrollment: 25 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2014
U.S. locations: 1
States / cities: San Diego, California

Conditions: Pneumococcal Disease
Interventions: 20vPnC, 13vPnC; Biological
Lead sponsor: Pfizer; Industry
Eligibility: 18 Years to 49 Years
Enrollment: 1,710 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019
U.S. locations: 21
States / cities: Anaheim, California • Sacramento, California • San Jose, California + 16 more

Conditions: Neovascular Age-related Macular Degeneration
Interventions: Brolucizumab 6 mg, Aflibercept 2 mg; Drug
Lead sponsor: Novartis Pharmaceuticals; Industry
Eligibility: 50 Years and older
Enrollment: 151 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018
U.S. locations: 63
States / cities: Peoria, Arizona • Phoenix, Arizona • Arcadia, California + 56 more

Conditions: Asthma in Children
Interventions: AsthmaTuner, Asthma-Guidance and Prediction System; Device · Other
Lead sponsor: Mayo Clinic; Other
Eligibility: 6 Years to 17 Years
Enrollment: 49 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Mental Health Issue
Interventions: Virtual Psychiatric Transition of Care Program; Behavioral
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 18 Years and older
Enrollment: 7,526 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2023
U.S. locations: 7
States / cities: Charlotte, North Carolina • Davidson, North Carolina • Kings Mountain, North Carolina

Conditions: Influenza, Influenza Immunisation
Interventions: Influenza Virus Quadrivalent Inactivated Vaccine; Biological
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID); NIH
Eligibility: 9 Years to 99 Years
Enrollment: 152 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2020
U.S. locations: 2
States / cities: Rochester, New York

Search by objective public record fields.

Efficacy and Safety Study of Caldolor (Intravenous Ibuprofen) in Hospitalized Adult and Pediatric Burn Patients

Livionex Oral Microbiome and Dental Plaque Control in HSCT Recipients

Molecular Optimization Via Exercise (MOVE)

Clinical Performance Evaluation of the CareSuperb™ COVID-19 Antigen Home Test

Virtual Reality and Standard Care vs. Standard Care Alone for Acute MSK Pain in Geriatric ED Patients

Pharmacokinetic (PK) and Safety Study of Meropenem in Young Infants With Intra-abdominal Infections

Voriconazole in Preventing Fungal Infections in Children With Neutropenia After Chemotherapy

Selective Early Medical Treatment of Patent Ductus Arteriosus in Extremely Low Gestational Age Infants: A Pilot RCT

Study to Describe the Safety, Tolerability, Immunogenicity, and Efficacy of RNA Vaccine Candidates Against COVID-19 in Healthy Individuals

Human Brain Antioxidants During Oxidative Stress

Pneumococcal Post-Vaccination Titers

Pre-operative Chemotherapy Plus Bevacizumab With Early Salvage Therapy Based on PET Assessment of Response in Patients With Locally Advanced But Resectable Gastric and GEJ Adenocarcinoma

Moderating the Negative Impact of Abnormal Screening Mammograms

US and Neurodevelopmental Outcomes in the Neonatal Intensive Care Unit (NICU)

BARDA Securing Anthrax Immunity For the Elderly

Impact of Sulphonylureas on Neurodevelopmental Outcomes in KCNJ11-related Intermediate Developmental Delay, Epilepsy and Neonatal Diabetes (iDEND) Syndrome

Leridistim Compared With Filgrastim in Treating Older Patients With Acute Myeloid Leukemia

A Study to Evaluate the Relationship Between Use of Albuterol Multidose Dry Powder Inhaler With an eModule (eMDPI) and Exacerbations in Participants With Asthma

Genetic Investigation of Solid Tumors Cohort

Trial to Evaluate the Safety and Immunogenicity of 3 Lots of 20-valent Pneumococcal Conjugate Vaccine in Pneumococcal Vaccine-Naïve Adults

Study of Safety and Efficacy of Brolucizumab 6 mg Drug Product Intended for Commercialization in Patients With nAMD

A Study of Remote Asthma Management Using an Integrated Artificial Intelligence-assisted EHR Dashboard and Mobile Device Compared With Usual Asthma Care to Treat 6-17 Year Old Patients

An Evaluation of Virtual Psychiatric Transition of Care Offered in Behavioral Health

Age and Response to Flu Vaccines